MedPath

Safety and Efficacy of Study Drug Versus Placebo for Negative Symptoms of Schizophrenia

Phase 2
Completed
Conditions
Schizophrenia
Registration Number
NCT00063297
Lead Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Brief Summary

This study is to determine the efficacy (how well the drug works), safety, and side effects of the study medication compared to placebo in the treatment of the negative symptoms of schizophrenia in adults.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
180
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (28)

Clinical Innovations

๐Ÿ‡บ๐Ÿ‡ธ

Santa Ana, California, United States

University of Mississippi Medical Center-Dept. of Psychiatry

๐Ÿ‡บ๐Ÿ‡ธ

Jackson, Mississippi, United States

Psychiatric Institute of Washington

๐Ÿ‡บ๐Ÿ‡ธ

Washington, DC, District of Columbia, United States

CNS Research Institute

๐Ÿ‡บ๐Ÿ‡ธ

Clementon, New Jersey, United States

Berma Research Group

๐Ÿ‡บ๐Ÿ‡ธ

Hialeah, Florida, United States

Med Psych Specialists, LLC

๐Ÿ‡บ๐Ÿ‡ธ

Atlanta, Georgia, United States

Quantum Laboratories

๐Ÿ‡บ๐Ÿ‡ธ

Pompano Beach, Florida, United States

University Hills Clinical Research

๐Ÿ‡บ๐Ÿ‡ธ

Irving, Texas, United States

Behavioral Medical Research of Staten Island, P.C.

๐Ÿ‡บ๐Ÿ‡ธ

Staten Island, New York, United States

Neurobehavioral Research

๐Ÿ‡บ๐Ÿ‡ธ

Lawrence, New York, United States

Research Strategies

๐Ÿ‡บ๐Ÿ‡ธ

Torrance, California, United States

Segal Institute for Clinical Research

๐Ÿ‡บ๐Ÿ‡ธ

North Miami, Florida, United States

Alexian Brothers Behavioral Health Hospital

๐Ÿ‡บ๐Ÿ‡ธ

Hoffman Estates, Illinois, United States

Global Research & Consulting

๐Ÿ‡บ๐Ÿ‡ธ

Olean, New York, United States

Bayley Seton Campus-Psychiatric Research Division

๐Ÿ‡บ๐Ÿ‡ธ

Staten Island, New York, United States

MedLabs Research of Houston

๐Ÿ‡บ๐Ÿ‡ธ

Houston, Texas, United States

NorthCoast Clinical Trials

๐Ÿ‡บ๐Ÿ‡ธ

Beachwood, Ohio, United States

Optimum Health Services

๐Ÿ‡บ๐Ÿ‡ธ

La Mesa, California, United States

IPR

๐Ÿ‡บ๐Ÿ‡ธ

Cerritos, California, United States

Synergy Clinical Research

๐Ÿ‡บ๐Ÿ‡ธ

Chula Vista, California, United States

Midwest Center for Neurobehavioral Medicine

๐Ÿ‡บ๐Ÿ‡ธ

Oakbrook Terrace, Illinois, United States

Birmingham Psychiatry Pharmaceutical Studies, Inc.

๐Ÿ‡บ๐Ÿ‡ธ

Birmingham, Alabama, United States

Sierra Vista Hospital

๐Ÿ‡บ๐Ÿ‡ธ

Sacramento, California, United States

University of Colorado

๐Ÿ‡บ๐Ÿ‡ธ

Denver, Colorado, United States

IPS Research

๐Ÿ‡บ๐Ÿ‡ธ

Oklahoma City, Oklahoma, United States

Vanderbilt University Medical Center

๐Ÿ‡บ๐Ÿ‡ธ

Nashville, Tennessee, United States

Community Clinical Research

๐Ÿ‡บ๐Ÿ‡ธ

Austin, Texas, United States

Milwaukee VA Medical Center

๐Ÿ‡บ๐Ÿ‡ธ

Milwaukee, Wisconsin, United States

ยฉ Copyright 2025. All Rights Reserved by MedPath